NCBiotech News

BioAgilytix Labs, a fast-growing Durham laboratory providing contract testing for pharmaceutical and biotechnology companies, has added two new high-efficiency testing devices to its arsenal.

G1 Therapeutics, a Chapel Hill company commercializing radiation-protection technology developed at the University of North Carolina at Chapel Hill, has raised $12.5 million in Series A funding.

At least two life science companies are among the 24 startups competing for NC IDEA grants worth as much as $50,000 apiece.
 

Just two years after breaking ground on a $70 million, 147,000-square-foot R&D expansion at its sprawling Research Triangle Park campus, Syngenta Biotechnology has announced another $94 million addition to the site.
 

Two North Carolina life-science collaborations are among five award winners in last week’s second annual Przirembel Prize competition at the InnoVenture Conference in Greenville, South Carolina.

• Syngenta announces plans to begin construction on new biotechnology research facilities in Research Triangle Park
• New facilities will include all-glass, climate-controlled greenhouses and precision growth chambers to study agronomic traits
• Construction is scheduled to begin in summer 2011